Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
ETS1 encodes a member of the ETS family of transcription factors, which are defined by the presence of a conserved ETS DNA-binding domain that recognizes the core consensus DNA sequence GGAA/T in target genes. Additionally we are shipping V-Ets erythroblastosis Virus E26 Oncogene Homolog 1 (Avian) Kits (13) and V-Ets erythroblastosis Virus E26 Oncogene Homolog 1 (Avian) Proteins (11) and many more products for this protein.
Showing 10 out of 151 products:
Human Polyclonal ETS1 Primary Antibody for EIA, FACS - ABIN952130
Harris, Yamakuchi, Kondo, Oettgen, Lowenstein: Ets-1 and Ets-2 regulate the expression of microRNA-126 in endothelial cells. in Arteriosclerosis, thrombosis, and vascular biology 2010
Show all 4 references for ABIN952130
Human Monoclonal ETS1 Primary Antibody for EIA, IF - ABIN1107150
Chen, Shin, Lin: Ets1 was significantly activated by ERK1/2 in mutant K-ras stably transfected human adrenocortical cells. in DNA and cell biology 2005
Show all 3 references for ABIN1107150
Human Monoclonal ETS1 Primary Antibody for EIA, IHC (p) - ABIN1107151
Kessler, Schroeder, Brar, Handwerger: Transcription factor ETS1 is critical for human uterine decidualization. in Molecular human reproduction 2006
Show all 3 references for ABIN1107151
Human Polyclonal ETS1 Primary Antibody for IF, IHC - ABIN1532334
Gao, Peng, Liang, Shahbaz, Liu, Wang, Sun, Niu, Niu, Liu, Wang, Lin, Wang, Niu: β6 integrin induces the expression of metalloproteinase-3 and metalloproteinase-9 in colon cancer cells via ERK-ETS1 pathway. in Cancer letters 2014
Chicken Polyclonal ETS1 Primary Antibody for IHC, WB - ABIN2792530
Yordy, Li, Sementchenko, Pei, Muise-Helmericks, Watson: SP100 expression modulates ETS1 transcriptional activity and inhibits cell invasion. in Oncogene 2004
Ets-1 links glucotoxicity to pancreatic beta cell dysfunction through inhibiting PDX-1 (show PDX1 Antibodies) expression in type 2 diabetes.
Akt2 (show AKT2 Antibodies) upregulates dendritic cell migration at least in part by ETS1-dependent stimulation of IP3R2 (show ITPR2 Antibodies) transcription.
The short nose, otitis media, and hearing impairment in Jacobsen syndrome are likely because of hemizygosity for ETS1 and FLI1 (show FLI1 Antibodies).
Ets1 and Sox10 (show SOX10 Antibodies) interact to promote proper melanocyte and enteric ganglia development from the neural crest.
our data suggested that ESE1/ELF3 (show ELF3 Antibodies) may promote the UC progression via accelerating NF-kappaB (show NFKB1 Antibodies) activation and thus facilitating IEC apoptosis.
maintenance of appropriate c-ets-1 levels is essential to prevent loss of self-tolerance in the B cell compartment.
Data indicate interactions between Ets1 transcription factor and two of its important regulators: Lyn (show LYN Antibodies), which maintains Ets1 expression to limit the differentiation of autoreactive plasma cells (PCs), and Btk (show BTK Antibodies).
our results demonstrate that both Ets1 and miR (show MLXIP Antibodies)-155 can directly regulate the expression of CD1d (show CD1D Antibodies) on B-cells
Data suggest that the long-term effect of curcumin may attenuate cancer progression via the down-regulation of tumor necrosis factor-alpha (TNF-alpha (show TNF Antibodies)) and interleukin-6 (IL-6 (show IL6 Antibodies)) modulated by E26 transformation-specific protein (ETS) and nuclear factor-kappaB (NF-kappaB (show NFKB1 Antibodies)).
Ets-1 has a role in fibronectin (show FN1 Antibodies)-derived heparin-binding domain polypeptides alleviating melanoma cell invasiveness and chemoresistance
the markers Ets-1 and APAF-1 (show APAF1 Antibodies) relative to p53 (show TP53 Antibodies), Ki-67 (show MKI67 Antibodies) and PTEN (show PTEN Antibodies) expression in colon adenomas/polyps, were investigated.
NR4As regulate gene transcription primarily through interaction with distal enhancers that are co-enriched for NR4A1 (show NR4A1 Antibodies) and ETS transcription factor (show FEV Antibodies) motifs
A significant positive correlation was seen between ETS-1 rs73013527 and RA susceptibility. Carriers of the haplotype CCT (show FLVCR2 Antibodies) or TCT (show TRPM7 Antibodies) for rs4937333, rs11221332 and rs73013527 had decreased risk. No effect was seen for rs10893872, rs4937333 and rs11221332.
MiR (show MLXIP Antibodies)-324-5p suppresses hepatocellular carcinoma cell invasion by counteracting extracellular matrix degradation through post-transcriptionally downregulating ETS1 and SP1 (show PSG1 Antibodies).
Demonstrate that TrkB (show NTRK2 Antibodies) protects endothelial integrity during atherogenesis by promoting Ets1-mediated VE-cadherin (show CDH5 Antibodies) expression and plays a previously unknown protective role in the development of coronary artery disease.
By investigating the role of ERa in the ETS-1 activity regulation, we demonstrated that ERalpha (show ESR1 Antibodies) may be a novel ETS-1 co-activator and thus a potential therapeutic target in human neuroblastoma (show ARHGEF16 Antibodies) treatment
Manipulation of the miR (show MLXIP Antibodies)-221/222-Ets-1-p21 (show CDKN1A Antibodies) pathway may offer a novel strategy for treatment of endothelial apoptosis.
As miR (show MLXIP Antibodies)-377 was found to be differentially expressed in clear cell renal carcinoma (show TSC2 Antibodies), and in light of the apparent central role of ETS1 in tumor development, these results indicate that miR (show MLXIP Antibodies)-377 could be useful for diagnostics, prognostics and therapeutics.
Data show that proto-oncogene (show RAB1A Antibodies) protein ETS1 transiently forms dimers as a consequence of interacting with any DNA sequence.
Data show that NF-kappa-B (show NFKB1 Antibodies) p52 (show FKBP4 Antibodies) subunit (p52 (show FKBP4 Antibodies)) interacts with ets transcription factors ETS1/2 factors at the C250T telomerase (TERT (show TERT Antibodies)) promoter to mediate TERT (show TERT Antibodies) reactivation.
The activity of Gata4 (show GATA4 Antibodies) cardiac enhancer in transgenic embryos and in cultured aortic endothelial cells is dependent on four ETS sites.
Ets-1 up-regulation is involved in the development of retinal neovascularization.
This gene encodes a member of the ETS family of transcription factors, which are defined by the presence of a conserved ETS DNA-binding domain that recognizes the core consensus DNA sequence GGAA/T in target genes. These proteins function either as transcriptional activators or repressors of numerous genes, and are involved in stem cell development, cell senescence and death, and tumorigenesis. Alternatively spliced transcript variants encoding different isoforms have been described for this gene.
v-ets erythroblastosis virus E26 oncogene homolog 1
, Ets protein
, v-ets erythroblastosis virus E26 oncogene homolog 1 (avian)
, protein c-ets-1-B
, C-ets-1 protein (p54)
, avian erythroblastosis virus E26 oncogene 1
, protein C-ets-1
, tumor progression locus 1
, ELK channel 3
, ether-a-go-go-like potassium channel 1
, ether-a-go-go-like potassium channel 3
, potassium voltage-gated channel subfamily H member 8
, potassium voltage-gated channel, subfamily H, member 8
, voltage-gated potassium channel subunit Kv12.1
, Avian erythroblastosis virus E26 (v-ets) oncogene homolog-1
, ets protein
, v-ets avian erythroblastosis virus E2 oncogene homolog 1
, Ets avian erythroblastosis virus E2 oncogene homolog 1 (tumor progression locus 1)
, TNFAIP3 interacting protein 1
, c-ets-1 oncogene
, p54 transcription factor
, transforming protein p54/c-ets-1
, transforming protein p68/c-ets-1
, virion-associated nuclear-shuttling protein
, v-ets erythroblastosis virus E26 oncogene-like protein 1